Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-26-338651
Filing Date
2026-08-06
Accepted
2026-08-06 18:50:40
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 17823
  Complete submission text file 0001193125-26-338651.txt   19736
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Subject) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-88987 | Film No.: 261250879
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 450 DULEY ROAD EL SEGUNDO CA 90245
Business Address 450 DULEY ROAD EL SEGUNDO CA 90245 310-836-6400
Cambridge Equities, LP (Filed by) CIK: 0001629222 (see all company filings)

EIN.: 452968305 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13D/A